Oxford BioMedica PLC OXBDF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
13.93UNCH (UNCH)
52 week range
4.51 - 14.60

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.93
  • 52 Week High14.60
  • 52 Week High Date12/31/20
  • 52 Week Low4.51
  • 52 Week Low Date03/18/20
  • Market Cap1,159.66M
  • Shares Out82.05M
  • 10 Day Average Volume1,802.78
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change69.46

RATIOS/PROFITABILITY

  • EPS (TTM)-0.20
  • P/E (TTM)-68.66
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Oxford BioMedica PLC News

There is no recent news for this security.

Latest OXBDF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Oxford BioMedica Plc is a gene and cell therapy company. The Company and its subsidiaries has developed lentiviral vector delivery platform (LentiVector), which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, liver and central nervous system (CNS) disorders. The Company's product pipeline...
Roch Doliveux
Non-Executive Chairman
John Dawson
Chief Executive Officer
Nick Page
Chief Operating Officer
Stuart Paynter
Chief Financial Officer
James Miskin
Chief Technology Officer
Natalie Walter
General Counsel
Address
Windrush Court, Transport Way
Oxford
OX4 6LT
United Kingdom